BLEPHAMIDE
LOE ApproachingNDAOPHTHALMICSUSPENSION
Approved
Sep 1961
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BLEPHAMIDE by AbbVie is clinical pharmacology corticosteroids suppress the inflammatory response to a variety of agents and they probably delay or slow healing. Approved for inflammatory conditions of the palpebral, bulbar conjunctiva, cornea and 7 more indications. First approved in 1961.
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BLEPHAMIDE is a fixed-dose ophthalmic suspension combining a corticosteroid with sulfacetamide sodium antibiotic for topical eye use. It treats inflammatory conditions of the eye including conjunctivitis, uveitis, and corneal injuries from chemical, radiation, or thermal burns. The corticosteroid suppresses inflammation while sulfacetamide provides bacteriostatic coverage against susceptible gram-positive and gram-negative organisms.
LOE Approaching
As an LOE-approaching legacy product with approaching loss of exclusivity, the brand team is likely focused on lifecycle management and transitioning patient share rather than growth initiatives.
Mechanism of Action
CLINICAL PHARMACOLOGY Corticosteroids suppress the inflammatory response to a variety of agents and they probably delay or slow healing. Since corticosteroids may inhibit the body's defense mechanism against infection, a concomitant antibacterial drug may be used when this inhibition is considered…
Indications (10)
Worked on BLEPHAMIDE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.